Qureshi, Adnan I <br/><br/>
Intra-arterial reteplase and intravenous abciximab in patients with acute ischemic stroke: an open-label, dose-ranging, phase I study.  [electronic resource] 

 -  Neurosurgery  Oct 2006 
 - 789-96; discussion 796-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1524-4040 
<br/><br/><label>Standard No.: </label>10.1227/01.NEU.0000232862.06246.3D  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Abciximab<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antibodies, Monoclonal--administration & dosage<br/>Arterial Occlusive Diseases--complications<br/>Brain Ischemia--complications<br/>Carotid Arteries<br/>Cerebral Angiography<br/>Cerebral Hemorrhage--chemically induced<br/>Female<br/>Fibrinolytic Agents--administration & dosage<br/>Humans<br/>Immunoglobulin Fab Fragments--administration & dosage<br/>Injections, Intra-Arterial<br/>Injections, Intravenous<br/>Male<br/>Middle Aged<br/>Platelet Aggregation Inhibitors--administration & dosage<br/>Platelet Glycoprotein GPIIb-IIIa Complex--antagonists & inhibitors<br/>Recombinant Proteins--administration & dosage<br/>Stroke--drug therapy<br/>Tissue Plasminogen Activator--administration & dosage